No Fear of Recourse—Greater Assurance When Prescribing^SilneaIBD for Chronic Inflammatory Bowel Diseases

An adequate supply of energy and nutrients is an important part of the care for patients with chronic inflammatory bowel diseases such as Crohn’s disease or ulcerative colitis. Sometimes a normal diet is not sufficient to ensure adequate nutrition or to achieve therapeutic success through other treatment measures. In such cases, enteral nutrition—for example, in the form of the oral nutritional supplement^SilneaIBD—is medically necessary and may be prescribed in accordance with the requirements of the Medicines Directive (AMR).

Careful documentation of the patient’s initial medical condition and previous interventions is important to clearly record and justify the necessity of this therapy.

What should you document to ensure a prescription for^SilneaIBD is protected against claims for reimbursement?

1. Patient information, including personal and anthropometric data
2. Nutritional status assessed using a recognized screening method (MUST Screening Tool)
3. Weight changes, if applicable
4. Evaluation of alternative measures to improve nutritional status in accordance with AMR §21
5. Individual^SilneaIBD requirements^{( SilneaIBD} Daily Requirement Calculator)
6. Information on prescribing^SilneaIBD

Please use our pre-formatted documentation form for this purpose.